Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation.

Authors:
Gaetano Calabrese Cristen Molzahn Thibault Mayor

J Biol Chem 2022 May 25;298(7):102062. Epub 2022 May 25.

Michael Smith Laboratories, University of British Columbia, Vancouver British Columbia, Canada. Electronic address:

The accumulation of protein inclusions is linked to many neurodegenerative diseases that typically develop in older individuals, due to a combination of genetic and environmental factors. In rare familial neurodegenerative disorders, genes encoding for aggregation-prone proteins are often mutated. While the underlying mechanism leading to these diseases still remains to be fully elucidated, efforts in the past 20 years revealed a vast network of protein-protein interactions that play a major role in regulating the aggregation of key proteins associated with neurodegeneration. Misfolded proteins that can oligomerize and form insoluble aggregates associate with molecular chaperones and other elements of the proteolytic machineries that are the frontline workers attempting to protect the cells by promoting clearance and preventing aggregation. Proteins that are normally bound to aggregation-prone proteins can become sequestered and mislocalized in protein inclusions, leading to their loss of function. In contrast, mutations, posttranslational modifications, or misfolding of aggregation-prone proteins can lead to gain of function by inducing novel or altered protein interactions, which in turn can impact numerous essential cellular processes and organelles, such as vesicle trafficking and the mitochondria. This review examines our current knowledge of protein-protein interactions involving several key aggregation-prone proteins that are associated with Alzheimer's disease, Parkinson's disease, Huntington's disease, or amyotrophic lateral sclerosis. We aim to provide an overview of the protein interaction networks that play a central role in driving or mitigating inclusion formation, while highlighting some of the key proteomic studies that helped to uncover the extent of these networks.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbc.2022.102062DOI Listing
May 2022

Publication Analysis

Top Keywords

aggregation-prone proteins
16
protein inclusions
8
interaction networks
8
proteins associated
8
protein interaction
8
protein-protein interactions
8
neurodegenerative diseases
8
proteins
7
protein
5
aggregates associate
4
posttranslational modifications
4
mislocalized protein
4
inclusions leading
4
leading loss
4
loss function
4
function contrast
4
contrast mutations
4
mutations posttranslational
4
modifications misfolding
4
proteins sequestered
4

Keyword Occurance

Similar Publications

Hsp multichaperone complex buffers pathologically modified Tau.

Authors:
Antonia Moll Lisa Marie Ramirez Momchil Ninov Juliane Schwarz Henning Urlaub Markus Zweckstetter

Nat Commun 2022 Jun 27;13(1):3668. Epub 2022 Jun 27.

German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075, Göttingen, Germany.

Alzheimer's disease is a neurodegenerative disorder in which misfolding and aggregation of pathologically modified Tau is critical for neuronal dysfunction and degeneration. The two central chaperones Hsp70 and Hsp90 coordinate protein homeostasis, but the nature of the interaction of Tau with the Hsp70/Hsp90 machinery has remained enigmatic. Here we show that Tau is a high-affinity substrate of the human Hsp70/Hsp90 machinery. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera).

Authors:
Chang Hoon Ji Min Ju Lee Hee Yeon Kim Ah Jung Heo Daniel Youngjae Park Yun Kyung Kim Bo Yeon Kim Yong Tae Kwon

Autophagy 2022 Jun 26:1-4. Epub 2022 Jun 26.

Cellular Degradation Biology Center, Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Korea.

Targeted protein degradation allows targeting undruggable proteins for therapeutic applications as well as eliminating proteins of interest for research purposes. While several types of degraders that harness the proteasome or the lysosome have been developed, a technology that simultaneously degrades targets and accelerates cellular autophagic flux remains unavailable. In this study, we developed a general chemical tool by which given intracellular proteins are targeted to macroautophagy for lysosomal degradation. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Disease modification in Parkinsonism: obstacles and ways forward.

Authors:
M Höllerhage M Klietz G U Höglinger

J Neural Transm (Vienna) 2022 Jun 13. Epub 2022 Jun 13.

Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

To date, the diagnoses of Parkinson syndromes are based on clinical examination. Therefore, these specific diagnoses are made, when the neuropathological process is already advanced. However, disease modification or neuroprotection, is considered to be most effective before marked neurodegeneration has occurred. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

A New Perspective on Huntington's Disease: How a Neurological Disorder Influences the Peripheral Tissues.

Authors:
Laura Gómez-Jaramillo Fátima Cano-Cano María Del Carmen González-Montelongo Antonio Campos-Caro Manuel Aguilar-Diosdado Ana I Arroba

Int J Mol Sci 2022 May 29;23(11). Epub 2022 May 29.

Undad de Investigación, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz (INiBICA), 11002 Cádiz, Spain.

Huntington's disease (HD) is a neurodegenerative disorder caused by a toxic, aggregation-prone expansion of CAG repeats in the HTT gene with an age-dependent progression that leads to behavioral, cognitive and motor symptoms. Principally affecting the frontal cortex and the striatum, mHTT disrupts many cellular functions. In fact, increasing evidence shows that peripheral tissues are affected by neurodegenerative diseases. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

High-Pressure, Low-Temperature Induced Unfolding and Aggregation of Monoclonal Antibodies: Role of the Fc and Fab Fragments.

Authors:
Jordan E Berger Susana C M Teixeira Kaelan Reed Vladimir I Razinkov Christopher J Sloey Wei Qi Christopher J Roberts

J Phys Chem B 2022 Jun 8;126(24):4431-4441. Epub 2022 Jun 8.

Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware 19716, United States.

The effects of high pressure and low temperature on the stability of two different monoclonal antibodies (MAbs) were examined in this work. Fluorescence and small-angle neutron scattering were used to monitor the effects of pressure to infer shifts in tertiary structure and characterize aggregation prone intermediates. Partial unfolding was observed for both MAbs, to different extents, under a range of pressure/temperature conditions. Read More

View Article and Full-Text PDF
June 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap